ketanserin has been researched along with Diabetic Feet in 3 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Topical ketanserin is a valuable therapy for difficult-to-treat leg ulcers." | 9.12 | Healing effect of ketanserin on chronic leg ulcers in patients with diabetes. ( Cauwenbergh, G; Kharfi, M; Paquet, P; Piérard, GE; Quatresooz, P; Vroome, V, 2006) |
| "The objective of this study was to determine the efficacy of topically applied ketanserin for healing acceleration of diabetic foot ulcers." | 9.08 | Randomized single-blind trial of topical ketanserin for healing acceleration of diabetic foot ulcers. ( Castañeda, M; García-Alonso, J; Martínez-de Jesús, FR; Mendiola-Segura, I; Morales-Guzmán, M; Pérez-Morales, A, 1997) |
| "Pirfenidone (PFD) is a potent modulator of extracellular matrix." | 6.84 | Pirfenidone Accelerates Wound Healing in Chronic Diabetic Foot Ulcers: A Randomized, Double-Blind Controlled Trial. ( Armendariz-Borunda, J; Bojórquez-Sepúlveda, H; Castañeda-Gomez, J; Davila-Rodriguez, JR; Domínguez-Rosales, J; Garcia-Bañuelos, J; Gasca-Lozano, LE; Lucano-Landeros, S; Navarro-Partida, J; Ruiz-Arcos, MA; Ruiz-Mercado, H; Salazar-Montes, A; Sánchez-Parada, MG; Sandoval-Rodríguez, A; Santos-Garcia, A, 2017) |
| "Topical ketanserin is a valuable therapy for difficult-to-treat leg ulcers." | 5.12 | Healing effect of ketanserin on chronic leg ulcers in patients with diabetes. ( Cauwenbergh, G; Kharfi, M; Paquet, P; Piérard, GE; Quatresooz, P; Vroome, V, 2006) |
| "The objective of this study was to determine the efficacy of topically applied ketanserin for healing acceleration of diabetic foot ulcers." | 5.08 | Randomized single-blind trial of topical ketanserin for healing acceleration of diabetic foot ulcers. ( Castañeda, M; García-Alonso, J; Martínez-de Jesús, FR; Mendiola-Segura, I; Morales-Guzmán, M; Pérez-Morales, A, 1997) |
| "Pirfenidone (PFD) is a potent modulator of extracellular matrix." | 2.84 | Pirfenidone Accelerates Wound Healing in Chronic Diabetic Foot Ulcers: A Randomized, Double-Blind Controlled Trial. ( Armendariz-Borunda, J; Bojórquez-Sepúlveda, H; Castañeda-Gomez, J; Davila-Rodriguez, JR; Domínguez-Rosales, J; Garcia-Bañuelos, J; Gasca-Lozano, LE; Lucano-Landeros, S; Navarro-Partida, J; Ruiz-Arcos, MA; Ruiz-Mercado, H; Salazar-Montes, A; Sánchez-Parada, MG; Sandoval-Rodríguez, A; Santos-Garcia, A, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gasca-Lozano, LE | 1 |
| Lucano-Landeros, S | 1 |
| Ruiz-Mercado, H | 1 |
| Salazar-Montes, A | 1 |
| Sandoval-Rodríguez, A | 1 |
| Garcia-Bañuelos, J | 1 |
| Santos-Garcia, A | 1 |
| Davila-Rodriguez, JR | 1 |
| Navarro-Partida, J | 1 |
| Bojórquez-Sepúlveda, H | 1 |
| Castañeda-Gomez, J | 1 |
| Domínguez-Rosales, J | 1 |
| Ruiz-Arcos, MA | 1 |
| Sánchez-Parada, MG | 1 |
| Armendariz-Borunda, J | 1 |
| Quatresooz, P | 1 |
| Kharfi, M | 1 |
| Paquet, P | 1 |
| Vroome, V | 1 |
| Cauwenbergh, G | 1 |
| Piérard, GE | 1 |
| Martínez-de Jesús, FR | 1 |
| Morales-Guzmán, M | 1 |
| Castañeda, M | 1 |
| Pérez-Morales, A | 1 |
| García-Alonso, J | 1 |
| Mendiola-Segura, I | 1 |
3 trials available for ketanserin and Diabetic Feet
| Article | Year |
|---|---|
Pirfenidone Accelerates Wound Healing in Chronic Diabetic Foot Ulcers: A Randomized, Double-Blind Controlled Trial.
Topics: Adult; Aged; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Diabetic Foot; Disulfid | 2017 |
Healing effect of ketanserin on chronic leg ulcers in patients with diabetes.
Topics: Administration, Cutaneous; Aged; Chronic Disease; Diabetes Mellitus, Type 1; Diabetic Foot; Double-B | 2006 |
Randomized single-blind trial of topical ketanserin for healing acceleration of diabetic foot ulcers.
Topics: Administration, Topical; Aged; Combined Modality Therapy; Debridement; Diabetes Mellitus, Type 2; Di | 1997 |